Fuller & Thaler Asset Management Inc. decreased its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 7.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,862,523 shares of the business services provider's stock after selling 148,172 shares during the period. Fuller & Thaler Asset Management Inc. owned about 1.06% of Genpact worth $79,995,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently modified their holdings of G. SRH Advisors LLC bought a new stake in Genpact during the 4th quarter valued at approximately $26,000. Atlas Capital Advisors Inc. raised its stake in Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after purchasing an additional 216 shares during the period. Manchester Capital Management LLC bought a new stake in Genpact during the 4th quarter valued at approximately $38,000. GeoWealth Management LLC raised its stake in Genpact by 199.0% during the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after purchasing an additional 583 shares during the period. Finally, Smartleaf Asset Management LLC grew its holdings in Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after buying an additional 783 shares in the last quarter. Institutional investors own 96.03% of the company's stock.
Genpact Trading Up 1.2 %
G traded up $0.57 during trading hours on Tuesday, reaching $48.83. 341,374 shares of the company's stock traded hands, compared to its average volume of 1,329,063. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The firm has a 50-day moving average price of $49.76 and a 200 day moving average price of $46.42. The firm has a market capitalization of $8.58 billion, a PE ratio of 17.17, a PEG ratio of 1.84 and a beta of 1.06. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, sell-side analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.39%. The ex-dividend date of this dividend was Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio (DPR) is currently 23.94%.
Insider Transactions at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 2.80% of the company's stock.
Analyst Ratings Changes
Several equities analysts have weighed in on the company. Needham & Company LLC raised their price target on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday, February 7th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and lifted their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Mizuho lifted their target price on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Finally, Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and lifted their target price for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Five research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $50.38.
Check Out Our Latest Analysis on Genpact
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.